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Sel1L is an essential adaptor protein for the E3 ligase
Hrd1 in the endoplasmic reticulum (ER)-associated
degradation (ERAD), a universal quality-control
system in the cell; but its physiological role remains
unclear. Here we show thatmicewith adipocyte-spe-
cific Sel1L deficiency are resistant to diet-induced
obesity and exhibit postprandial hypertriglyceride-
mia. Further analyses reveal that Sel1L is indispens-
able for the secretion of lipoprotein lipase (LPL),
independent of its role in Hrd1-mediated ERAD and
ER homeostasis. Sel1L physically interacts with
and stabilizes the LPL maturation complex consist-
ing of LPL and lipase maturation factor 1 (LMF1). In
the absence of Sel1L, LPL is retained in the ER and
forms protein aggregates, which are degraded pri-
marily by autophagy. The Sel1L-mediated control of
LPL secretion is also seen in other LPL-expressing
cell types including cardiac myocytes and macro-
phages. Thus, our study reports a role of Sel1L in
LPL secretion and systemic lipid metabolism.
INTRODUCTION
Protein misfolding and aggregation in the endoplasmic reticulum
(ER) contribute significantly to the etiology and pathogenesis of
many devastating diseases, including type 1 diabetes, Creutz-
feldt-Jakob disease, and cystic fibrosis (Chiti and Dobson,
2006). ER-associated degradation (ERAD) targets misfolded
secretory and membrane proteins for proteasomal degradation
(Olzmann et al., 2013), while autophagy may be responsible for
the clearance of protein aggregates in the ER (Houck et al.,
2012). Failure to degrade misfolded proteins in the ER leads to458 Cell Metabolism 20, 458–470, September 2, 2014 ª2014 ElsevieER stress, activates unfolded protein response (UPR), and
initiates global changes in transcription and translation (Hetz,
2012). Together, they represent key quality-control systems
in the cell to maintain ER homeostasis and adjust ER capacity
in response to environmental cues. Despite recent advances in
the identification of many ERAD components (Olzmann et al.,
2013), little is known about their physiological roles. To date,
studies of ERAD mouse models have been very limited.
Hydroxymethylglutaryl reductase degradation protein 3
(Hrd3), or its mammalian homolog Sel-1 suppressor of lin-12-
like protein (Sel1L), is an ER-resident transmembrane protein
previously characterized as an adaptor protein for the E3 ligase
Hrd1 (Gardner et al., 2000; Grant and Greenwald, 1996; Hamp-
ton et al., 1996; Sundaram and Greenwald, 1993). Within the
ER, the Hrd3/Sel1L-Hrd1 complex targets a subset of misfolded
or unfolded proteins for proteasomal degradation (Gardner et al.,
2000; Mueller et al., 2006, 2008). In mice, loss of Sel1L leads to
embryonic lethality (Francisco et al., 2010), pointing to its impor-
tance in mammalian development. Using inducible mouse and
cell models, we recently showed that Sel1L controls Hrd1 stabil-
ity (similar to yeast homologs) and is indispensable for ER ho-
meostasis and ERAD in adult mice (Sun et al., 2014). However,
cell type-specific function of Sel1L and ERAD remains unknown.
LPL controls systemic lipid partitioning that is essential for
energy homeostasis of the body. LPL is most abundantly ex-
pressed in adipose tissue, macrophages, and myocytes, where
it acts as a gatekeeper for the entry of fatty acids into tissues
(Williams, 2008). LPL-mediated hydrolysis of dietary triglycerides
(TGs) packaged in chylomicrons is increased at adipose tissues
during feeding (to increase lipid storage), but suppressed during
fasting (Williams, 2008). Production of active LPL is tightly regu-
lated at multiple stages (Dijk and Kersten, 2014; Doolittle and
Peterfy, 2010; Wang and Eckel, 2009), one of which is in the
ER. Various ER chaperones are required for the folding of
nascent LPL polypeptides into properly folded dimeric state
(Ben-Zeev et al., 1992, 2002; Vannier and Ailhaud, 1989). Lipase
maturation factor 1 (LMF1), an ER-resident five-transmembraner Inc.
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dimers before the exit from the ER (Pe´terfy, 2012; Pe´terfy
et al., 2007). In the absence of LMF1, LPL forms aggregates, be-
comes transport incompetent, and is retained in the ER (Pe´terfy
et al., 2007). Defects in LPL maturation in the ER result in hyper-
triglyceridemia known as familial hyperchylomicronemia, which
contributes to the development of heart diseases, metabolic
syndrome, and other diseases in humans (Doolittle and Peterfy,
2010). Despite decades of effort, the maturation and secretion
processes of LPL in the ER remain poorly understood.
Interestingly, adipocyte-specific Sel1L-deficient mice (AKO
hereafter) are resistant to diet-induced obesity and develop
postprandial hypertriglyceridemia. Further investigations reveal
an unexpected role of Sel1L in regulating LPL secretion, inde-
pendent of its canonical role in Hrd1 and ERAD, not only in adi-
pocytes, but also in macrophages and myocytes. Thus, Sel1L
forms distinct functional complexes with Hrd1 and LPL.
RESULTS
Generation of AKO Mice
In vivo, Sel1L protein was highly expressed in the pancreas, liver,
and white adipose tissue (WAT), and moderately expressed in
brown adipose tissue (BAT), predominantly as an endoglycosi-
dase H (endoH)-sensitive protein (Figure S1A available online),
pointing to its ER localization. During adipogenesis, both Sel1L
and Hrd1 were highly induced (Figures S1B and S1C). Stable
knockdown of Sel1L or Hrd1 in 3T3-L1 preadipocytes had no
noticeable effect on adipogenesis (Figures S1D and S1E), sug-
gesting that they are dispensable for adipocyte differentiation.
Both Sel1L and Hrd1 are constitutively expressed in WAT (Fig-
ure S1F). Interestingly, Sel1L protein level was induced by 50%
upon refeeding with high-fat diet (HFD) in a transcription-inde-
pendent manner (Figures S1F and S1G). This induction was
not seen when mice were refed with low-fat diet (LFD) (Fig-
ure S1H). Thus, these data imply a possible role of Sel1L in lipid
metabolism in mature adipocytes.
We generated AKO mice by crossing the Sel1Lflox/flox mice
with the Cre-transgenic animals under the control of adipo-
cyte-specific adiponectin promoter (Figure S1I). AKO mice and
control littermates Sel1Lflox/flox (wild-type [WT]) were born at
the expected Mendelian ratios (Figure S1J). For some studies,
we also generated adipocyte-specific heterozygous mice (HET)
using a different breeding scheme (Figure S1K). Reduction of
Sel1L protein level was limited to WAT and BAT, and in the
case of WAT, specifically in adipocytes, not in stromal vesicular
cells (SVCs) (Figures 1A, 1B, and S1L).
Resistance to Diet-Induced Obesity of AKO Mice
AKO and WT littermates, both males and females, grew compa-
rably on LFD for the first 20 weeks of age (Figure S2A). To study
the role of Sel1L in obesity, we placed 6-week-old AKO and WT
littermates on HFD. Strikingly, both male and female AKO mice
were resistant to HFD-induced obesity (Figures 1C and 1D).
Dual-energy X-ray absorptiometry (DEXA) analyses revealed a
great reduction in fat mass, but not lean mass, in AKO mice
compared toWTmice following chronic HFD feeding (Figure 1E).
Indeed, following 16-week HFD, epididymal fat (EF) of AKOmice
weighed 67% less than that of WT littermates (Figures 1F andCell Me1G). Tissue histology revealed smaller epididymal adipocytes
of AKO mice (Figures 1H and 1I). Intriguingly, the livers of AKO
mice were enlarged and developed steatosis with elevated TG
contents (Figures 1J–1L). Moreover, serum TG levels of AKO
mice on HFD were significantly higher than those of WT litter-
mates (Figure 1M).
These changes were associated with elevated serum insulin
levels (Figure 1N) and accordingly increased expression of a
subset of de novo lipogenic genes in both the liver and WAT of
AKO mice on HFD (Figures S2B and S2C). Despite body weight
difference, fasting glucose as well as glucose and insulin toler-
ance was comparable between the two cohorts (Figures 1O–
1Q). Levels of AKT phosphorylation in the liver and muscle under
either ad libitum or postinsulin challenge conditions were com-
parable between the two cohorts (Figures S2D–S2F). Moreover,
food intake (Figure S2G), fecal energy recovery (Figures S2H and
S2I), and physical activity (Figure S2J) were comparable be-
tween the two cohorts. Interestingly, while respiratory quotient
(RQ) was similar, both oxygen (O2) consumption and carbon di-
oxide (CO2) production were higher in AKO mice on HFD than in
WT littermates (Figures S2K–S2M), suggesting increased meta-
bolic rate in AKO mice. Providing further support, rectal temper-
ature of AKO mice was higher than that of WT controls under
fasting and cold conditions (Figures S2N and S2O). Thus, we
conclude that AKO mice are resistant to diet-induced obesity
with lipid partitioning defect, and that increased metabolic rate
and thermogenesis may contribute, at least in part, to the lean
phenotype of AKO mice on HFD.
Postprandial Hypertriglyceridemia in AKO Mice
We next addressed whether adipose tissues of AKO mice are
intrinsically defective in lipid absorption. To circumvent body
weight differences in HFD mice, we measured serum TG levels
in LFD-fed littermates with similar body weights under fasting
and refeeding conditions. There was no difference in fasting
plasma TGs and glycerol levels (Figures 2A and 2B). However,
plasma TG levels in AKO mice were significantly higher than in
WT mice upon refeeding with either LFD or HFD by 50% or
2-fold, respectively (Figures 2C and 2D). Oral gavage of olive oil
also led to hypertriglyceridemia in AKO mice (Figure 2E). Fast
protein liquid chromatography (FPLC) analysis of fasting and re-
feeding plasma indicated that plasma TG-rich lipoproteins were
comparable between the two cohorts during fasting, but signifi-
cantly increased in AKO mice following refeeding (Figure 2F).
Plasma high-density lipoprotein (HDL) cholesterol remained un-
changed regardless of the feeding status (Figure 2G). Thus,
AKO mice on HFD exhibit postprandial hypertriglyceridemia.
ERRetention andAccumulation of LPL in the Absence of
Sel1L
Given the known role of LPL in postprandial hypertriglyceridemia
(Wang and Eckel, 2009), we examined the status of LPL in WAT
of AKO mice. Following refeeding, AKO mice exhibited lower
postheparin plasma LPL activity and mass compared to those
of WT mice (Figures 3A and 3B). The moderate change was ex-
pected given the relatively small proportion of LPL in WAT in the
total LPL pool. While tissue Lpl mRNA levels were comparable
(Figures 3C and S3A), total LPL protein level was 2- to 3-fold
higher in WAT of AKO mice on either LFD or HFD (Figures 3Dtabolism 20, 458–470, September 2, 2014 ª2014 Elsevier Inc. 459
Figure 1. Resistance to Diet-Induced Obesity and Altered Lipid Distribution in AKO Mice
(A and B) Immunoblots of Sel1L in white adipose tissues/brown adipose tissues (WATs/BATs) and liver of WT and AKO mice (A), and in primary adipocytes and
stromal vascular cells (SVCs) isolated from WAT (B). Relative Sel1L expression levels normalized to HSP90 shown below the blots.
(C) Body weights (BWs) of WT and AKO males (left) and females (right) fed HFD (n = 6 each).
(D) Representative picture of WT and AKO female mice fed HFD for 26 weeks.
(E) Fat and lean masses of WT and AKO males (left) and females (right) fed HFD as measured by dual-energy X-ray absorptiometry (DEXA) (n = 5–6 each).
(F) Representative pictures of WT and AKO males fed HFD for 16 weeks. L, liver; EF, epididymal fat.
(G) EF weight normalized to BW of mice in (F) (n = 11 each). Right, a representative image of EF.
(H) Representative hematoxylin and eosin (H&E) staining of EF sections from mice in (F).
(I) Histogram showing adipocyte area from (H) (n = 990 cells each).
(J–L) Liver weights (J) and total triglyceride (TG) in the liver (K) normalized to BW, and H&E staining of liver sections (L) of WT and AKOmice fed HFD for 16 weeks
(n = 10–11 each).
(M) Serum TG levels of 4-hr-fasted WT and AKO male mice fed HFD for 16 weeks (n = 6 each).
(N) Serum insulin levels of 4-hr-fasted male mice fed HFD for 16 weeks as determined by ELISA assay (n = 6 each).
(O) Blood glucose levels in WT and AKO males on HFD after an 18 hr fast (n = 6 each).
(P and Q) Glucose tolerance test (GTT) and insulin tolerance test (ITT) on males fed HFD for 13 weeks (n = 6–8 mice each). Right, area under the curve (AUC)
analysis.
Data are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; N.S., not significant by Student’s t test. HSP90, a loading control. See also Figures S1 and S2.
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Figure 2. Postprandial Hypertriglyceridemia of AKO Mice
(A and B) Plasma TG (A) and glycerol (B) levels in WT and AKO mice fasted overnight (n = 10–11 each).
(C and D) Plasma TG levels of WT and AKO mice refed LFD for 3 hr (C) or HFD for 4 hr (D) after an overnight fast (n = 9–12 each).
(E) Plasma TG levels at 2.5 hr post oral gavage with olive oil in mice fasted for 4 hr (n = 4–6 each).
(F and G) TG (F) and cholesterol (G) levels in lipoproteins by FPLC lipid profile analysis of plasma pooled from WT and AKO mice (n = 5 per genotype) that were
either fasted overnight or refed HFD for 4 hr following an overnight fast. VLDL, very-low-density lipoproteins; Chylo, chylomicrons; HDL, high-density lipoproteins.
Data are mean ± SEM. *p < 0.05, **p < 0.01; N.S., not significant by Student’s t test.
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but higher in WAT suggested a possible defect in LPL secretion.
Indeed, LPL protein was retained intracellularly: LPL secretion by
primary adipocytes isolated from AKOmice was only 10%–20%
of that of WT mice, despite 9-fold higher intracellular LPL levels
(Figures 3E and S3C). The secretory defect seemed to be LPL
specific, as secretion of adiponectin was normal in AKO adipo-
cytes (Figure 3E), and as general secretion was not affected in
AKO adipocytes (Figure S3D). Thus, our data show that Sel1L
is indispensable for LPL secretion in adipocytes.
Serendipitously, we noticed that LPL from adipose tissue and
primary adipocytes of AKO mice migrated faster than that from
WT samples following prolonged running of the SDS-PAGE (Fig-
ure 3F). This finding prompted us to examine the glycosylation
status of LPL. LPL is first synthesized and glycosylated, and
then undergoes partial trimming of oligosaccharide chains in
the ER. It is then transported to the Golgi where it is subject to
trimming of mannose residues and conversion of LPL oligosac-
charides into complex types (Ben-Zeev et al., 2002; Liu et al.,
1993). Mouse LPL has two potential N-linked glycosylation sites
required for the formation of active homodimers in the ER. The
high-mannose form of glycans found in the ER is endoH sensi-
tive, whereas the complex form of glycans found in the Golgi
apparatus or cell surface is endoH resistant; a mixture of the
two in the Golgi gives an intermediate phenotype (Vannier and
Ailhaud, 1989). Strikingly, the majority (83%) of LPL protein in
AKO WAT was endoH sensitive, two times higher than that in
WT WAT (Figure 3G), suggesting that Sel1L deficiency may
lead to the ER retention of LPL. This conclusion was further
confirmed biochemically using ER fractionation (Figure 3H).
To explore possible physiological significance of Sel1L, we
assessed the LPL status in WAT and BAT during the fasting-
feeding transition and cold exposure, respectively. Refeeding
increased total LPL protein levels in WAT of both WT and AKOCell Memice (Figures 3I and S3E), suggesting that AKO mice respond
to feeding normally. However, refeeding doubled the proportions
of the endoH-resistant form of LPL in WT WAT, but not in AKO
WAT (Figures 3I and S3E). In BAT, cold exposure increased
both total and endoH-resistant forms of LPL in WT mice, but
not in AKO mice (Figures 3J and S3F).
To further determine whether the effect of Sel1L on LPL secre-
tion is a general phenomenon, we examined the LPL behavior in
other LPL-expressing cells, including macrophages and myo-
cytes. Similar to the situation in AKO adipocytes, Sel1L-deficient
bone marrow-derived macrophages (BMDMs) from myeloid-
specific Sel1L-deficient (MKO) mice exhibited increased total
LPL protein levels, most of which were endoH sensitive (Fig-
ure 3K). Consistently, LPL secretion was reduced by 80% in
MKO BMDMs when compared to that of WT cells (Figure 3L).
Moreover, using cardiac muscle from the inducible Sel1L
knockout mice (IKO) we recently generated (Sun et al., 2014),
we observed that LPL accumulated by 2- to 3-fold upon acute
deletion of Sel1L, themajority of whichwas endoH sensitive (Fig-
ures 3M and 3N). Thus, our data establish that Sel1L is involved
in LPL secretion.
Defective ERAD and Elevated UPR in WAT of AKO Mice
We next explored possible molecular mechanisms underlying
Sel1L-mediated regulation of LPL secretion. We first determined
how Sel1L deficiency affects ERAD in adipocytes. In agreement
with our earlier study (Sun et al., 2014), the protein level of Hrd1
was greatly reduced, while that of EDEM1 and both isoforms of
OS9, bona fide substrates of the Sel1L-Hrd1 ERAD complex
(Sun et al., 2014), was dramatically elevated in WAT of AKO
mice (Figure 4A). Turnover of OS9 protein was blocked in AKO
adipocytes (Figure S4), pointing to a defective ERAD. Protein
levels of other E3 ligases such as Gp78 and RMA1 were not
altered in WAT of AKO mice (Figure 4A; data not shown). Thus,tabolism 20, 458–470, September 2, 2014 ª2014 Elsevier Inc. 461
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Figure 3. Sel1L Deficiency Leads to ER Retention of LPL
(A and B) LPL activity (A) and LPL mass (B) in postheparin plasma of LFD mice refed with HFD for 2 hr following an overnight fast (n = 4 each).
(C) Lpl mRNA levels in WAT of WT and AKO mice fed LFD by qPCR and normalized to L32 (n = 6 each).
(D) Immunoblots and quantitation (upper) of LPL in WAT of WT and AKO mice fed LFD (n = 4–5 each).
(E) Immunoblots of LPL and adiponectin in the culture medium of primary adipocytes, adipocytes, and SVC. Primary adipocytes isolated fromWAT of LFD mice
were cultured and incubated for 6 hr in the presence of 1 mg/ml insulin with or without 10 U/ml heparin. Quantitation of protein levels relative toWT (with heparin) in
medium and adipocytes shown below the blot.
(F) Immunoblots of LPL in WAT, BAT, and primary adipocytes to show the faster mobility shift of LPL in AKO samples.
(G) Western blot analysis of LPL inWAT lysates treated with endoH or PNGase F. Percent of endoH-resistant (r) + intermediate (i) and sensitive (s) LPL in total LPL
shown below.
(H) Representative immunoblots in the ER-enriched and cytosol fractions of WT and AKO WAT from two repeats. Quantitation of LPL shown below the blot.
(I and J) Immunoblots of LPL in endoH-treated WAT lysates of mice fasted overnight with or without refeeding with HFD for 2 hr (I) or BAT lysates of mice that
were kept at either 22C or 4C for 4 hr following an overnight fast (J). Right, quantitation of the percent of r+i LPL in total LPL (n = 3–4 each as shown in Figures
S3E and S3F).
(K) Western blot analysis of LPL in endoH-treated BMDM lysates from WT and macrophage-specific Sel1L-deficient (MKO) mice.
(L) Immunoblots of Sel1L and LPL in cell lysates and culture medium of BMDMs from WT and MKO mice after incubation for 3 hr in the presence of 10 U/ml
heparin. LPL levels relative to WT in BMDMs and medium shown below the blot.
(M andN)Western blot (M) and endoH (N) analysis of LPL in the heart lysates fromWT and inducibleSel1L knockout (IKO)mice. Quantitation shown below the gel.
Data are mean ± SEM. *p < 0.05; **p < 0.01; N.S., not significant by Student’s t test. HSP90, a loading control. *, a nonspecific band; a.u., arbitrary unit. See also
Figure S3.
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Role of Sel1L and Sel1L-Hrd1 ERAD in AdipocytesSel1L is indispensable for the stability and function of Hrd1, and
ERAD is compromised in the absence of Sel1L in adipocytes.
We next addressed whether ER homeostasis is disturbed in
WAT of AKO mice. Western blot analysis revealed an increase
of GRP78, ERO1L, and eIF2a phosphorylation in WAT of AKO
mice fed HFD compared to the WT cohorts (Figure 4B). Microar-
ray analysis revealed that selective UPR/ERAD genes and
pathways associated with ER homeostasis (e.g., ER protein pro-
cessing, UPR, and chaperone activation by IRE1a) were highly
upregulated (Figures 4C, 4D, S5A, and S5B). Consistently, mild
ER dilation was noted in white adipocytes of AKO mice fed
HFD (Figure S5C). Quantitative PCR (qPCR) analysis further
showed a mild induction of a subset of UPR genes, including
Grp78, Erdj4, P58ipk, Pdia6, and Ero1l as well as Xbp1 mRNA
splicing in WAT of AKO mice (Figures 4E and 4F).
Although UPR has been linked to cell death and inflammation
in vitro upon challenge with pharmacological drugs (Hotamisligil,
2010), we found no evidence of that in AKO mice as demon-
strated by the protein levels of caspase-3 cleavage and ATF3,
an inflammation-responsive gene involved in apoptosis (Hart-
man et al., 2004) (Figure 4G). In addition, expression of inflamma-
tory genes and JNK phosphorylation in WAT and serum levels of
inflammatory cytokines such as IL-6, IFN-g, and TNFa were not
affected by Sel1L deficiency (Figures 4H, S5D, and S5E). Thus,
Sel1L deficiency in WAT is associated with ERAD defect and
mild UPR, uncoupled from inflammation and cell death.
ER Stress-Independent Haploinsufficiency of Sel1L on
LPL Secretion
To determine whether UPR accounts for reduced LPL secretion
in Sel1L-deficient adipocytes, we addressed whether ER stress
is sufficient to cause LPL accumulation. Primary adipocytes
were treated with various ER stress inducers, including tunica-
mycin (Tm) and thapsigargin (Tg). Interestingly, neither drug
induced obvious LPL accumulation in adipocytes (Figure 4I).
By contrast, when treated with brefeldin A (BFA), which blocks
protein secretion, intracellular LPL level was elevated to a level
similar to that of AKO adipocytes (Figure 4I).
We next addressed whether Sel1L affects LPL secretion in a
dose-dependent manner using Sel1L HET mice. WAT of HET
mice had reduced Sel1L and Hrd1 expression by 50%, but no
UPR activation as shown by protein levels of GRP78 and
PDIA6 aswell as eIF2a phosphorylation (Figure 4J). Interestingly,
LPL behavior in WAT of HET mice exhibited an intermediate
phenotype compared to those of WT and AKO mice, including
total protein level, ER retention, and secretion (Figures 4K and
4L). In vivo, HETmice exhibited intermediate postprandial hyper-
triglyceridemia (Figure 4M). Lastly, while knockdown of Sel1L by
60% in 3T3-L1 adipocytes didn’t induce UPR (Figure S6A), it
significantly impaired LPL secretion, but not adiponectin or adip-
sin (Figure S6B). Thus, these data demonstrate an ER stress-
independent haploinsufficiency of Sel1L on LPL secretion.
Sel1L Regulates LPL Secretion Independent of
Hrd1-Mediated ERAD
We next investigated whether LPL accumulation in AKO adipo-
cytes is a direct result of ERAD dysfunction. To this end, we per-
formed translational shutoff assays using a translation inhibitor
cycloheximide (CHX) to assess the degradation rate of LPL in pri-Cell Memary adipocytes. Despite reduced secretion, AKO adipocytes
exhibited similar LPL decay as WT adipocytes (Figure 5A),
suggesting that LPL degradation was not blocked by Sel1L defi-
ciency. To determine whether LPL is degraded by proteasome/
ERAD or lysosome/autophagy, we treated primary adipocytes
with proteasome inhibitor MG132 or autophagy-specific inhibi-
tors 3-methyladenine (3-MA) and chloroquine in addition to
CHX. BFA was added to the culture medium to block LPL secre-
tion. While MG132 had a minor effect on LPL stability (Figure 5B,
lanes 12–14 and lanes 26–28), treatment with 3-MA or chloro-
quine largely blocked LPL degradation in both WT and AKO ad-
ipocytes (Figure 5B, lanes 5–11 and lanes 19–25) (quantitated in
Figure 5C). Similar observations were obtained in 3T3-L1 adipo-
cytes where chloroquine and 3-MA, but not MG132, attenuated
LPL degradation (Figure 5D). Thus, in line with an earlier study
(Ben-Zeev et al., 2002), proteasome-mediated ERAD does not
play a major role in the clearance of LPL in adipocytes. Rather,
our data show that autophagy is the primary mechanism for
the clearance of LPL in adipocytes.
To further examine the role of the E3 ligase Hrd1 in LPL, we
generated Hrd1-deficient adipocytes. Knockdown of Hrd1 by
90% in 3T3-L1 adipocytes failed to affect the secretion of LPL
(Figures S6C and S6D). Taken together, our data demonstrate
that ERAD and proteasome do not play a predominant role in
LPL degradation, and that Sel1L-mediated regulation of LPL
secretion is independent of Hrd1.
Sel1L Regulates the ER Exit of LPL and Prevents LPL
Aggregation
During LPL maturation in the ER, there is a delicate balance be-
tween dimerization and aggregation (Ben-Zeev et al., 2002). To
delineate how Sel1L deficiency affects LPL maturation, we per-
formed sucrose gradient sedimentation analysis to separate
active LPL dimers from inactive high-molecular-weight (HMW)
LPL-containing complexes in Triton X-100-soluble tissue ly-
sates. While 84% of LPL was clustered in the dimer fractions
of WT samples, only 46% of total LPL in AKO WAT was in the
dimer fractions (Figure 6A). Conversely, over half of LPL in
AKO WAT was in the HMW fractions versus only 13% in WT
WAT (Figure 6A). Next, we used a complementary approach to
fractionate adipocyte lysates into soluble and insoluble form us-
ing amilder detergent NP40 (Sakakibara et al., 1997;Wang et al.,
2011). Indeed, nearly 50% of LPL in AKO adipocytes at 4C
formed NP40-insoluble aggregates (NP40P), much higher than
in WT adipocytes (Figure 6B). Shifting culture temperature to
37C increased LPL aggregation by over 50% in AKO adipocytes
(Figure 6B), pointing to a dynamic formation of LPL aggregates in
the absence of Sel1L. Protein aggregation is known to induce
autophagy (Singh and Cuervo, 2012). Indeed, autophagic activ-
ity was increased in WAT of AKO mice as shown by elevated
conversion of LC3-I to LC3-II (Figure 6C). Thus, Sel1L deficiency
predisposes LPL to aggregate.
We next characterized LPL dimers in AKO adipocytes. We
performed endoH analysis of the fractions from the sucrose
gradient assay. Strikingly, 50% of LPL in the dimer fractions of
the AKO sample was endoH sensitive versus 9% in WT WAT
(Figure 6D, lane 4 versus lane 2), indicating that a large propor-
tion of LPL dimers in AKO WAT were retained in the ER. Of
note, for the HMW LPL, nearly all of them in AKO WAT weretabolism 20, 458–470, September 2, 2014 ª2014 Elsevier Inc. 463
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Figure 4. ERAD Defect and UPR Activation in WAT of AKO Mice and Haploinsufficiency of Sel1L on LPL Secretion
(A and B) Immunoblots of ERAD (A) and UPR (B) genes in WAT of WT and AKOmice fed HFD for 16 weeks. Protein levels normalized to HSP90 shown below the
blots (n = 3–6 each).
(C) Volcano plot of Affymetrix microarray analysis of WAT from WT and AKO mice fed HFD for 5 weeks (n = 4 each) with top upregulated UPR/ERAD genes
highlighted.
(D) Top three upregulated pathways in AKOWAT by gene set enrichment analysis (GSEA) of Affymetrix microarray in (C) (false discovery rate or FDR q < 0.0002).
(E) qPCR analysis of UPR genes normalized to L32 in WAT of mice fed HFD for 16 weeks (n = 6 each).
(F) Real-time PCR and qPCR analyses of Xbp mRNA splicing in WAT and primary adipocytes. HET, adipocyte-specific Sel1l+/ mice. L32, a loading control.
Percent of Xbp1s in total Xbp1 (Xbp1u + Xbp1s) shown below. Right, relative ratio of Xbp1s to total Xbp1mRNA levels inWAT ofWT and AKOmice by qPCR (n = 6
each).
(G) Immunoblots of caspase-3 and ATF3 in WAT of WT and AKO mice fed HFD for 16 weeks. The ratio of cleaved to pro-caspase-3 and protein level of ATF3
shown below the blots (n = 6 each).
(H) Inflammatory gene expression normalized to L32 in WAT of mice fed HFD for 16 weeks by qPCR (n = 6 each).
(legend continued on next page)
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Figure 5. LPL Degradation Is Mediated by Autophagy, Independent of ERAD and Proteasome
(A) Western blot analysis of LPL in culture medium and cells of primary adipocytes treated with 50 mg/ml cycloheximide (CHX) for the indicated time. LPL protein
levels were normalized to that at 10 min and LPL levels in the medium relative to WT at 240 min shown below the blots. l.e., long exposure.
(B)Western blot analysis of LPL in primary adipocytesmaintained in 1 mg/ml BFA and 1 mg/ml insulin, and treatedwith 50 mg/ml CHX in the presence or absence of
5 mM 3-methyladenine (3-MA), 200 mM chloroquine (Chl), or 25 mM MG132 for the indicated time.
(C) Quantitation of LPL as in (B) from three experiments.
(D) Immunoblots of LPL in 3T3-L1 adipocytes mock-treated or treated with 50 mg/ml CHXwith or withoutMG132, Chl, and 3-MA for 6 hr. Cells were cultured in the
presence of 0.4 mg/ml BFA and 1 mg/ml insulin.
Data are mean ± SEM. HSP90, a loading control. See also Figure S6.
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Role of Sel1L and Sel1L-Hrd1 ERAD in AdipocytesendoH sensitive versus 43% in WT samples (Figure 6D, lanes 8
and 12 versus lane 10).
We next compared LPL activity inWAT of LMF1- versus Sel1L-
deficient mice. As Lmf1-global knockout mice are embryonic le-
thal (M.P. and N.E., unpublished data), we generated inducible
Lmf1-deficient mice. LMF1 deficiency caused LPL accumulation
in WAT, similar to that in AKO WAT (Figure 6E). Interestingly,
while LMF1 deficiency abolished LPL activity, total LPL activity
in WAT of AKOmice was higher than that of WTmice (Figure 6E).
These data were in line with the amount of LPL dimers in AKO
WAT (Figure 6A), suggesting that the dimers retained in the ER
of AKO cells were active. Hence, LMF1 and Sel1L may affect
different stages of LPL biogenesis: while LMF1 is required for
LPL dimerization, Sel1L controls the ER exit of active LPL
dimers.
Sel1L Forms a Complex with LPL-LMF1
To further dissect themolecular mechanism underlying the role of
Sel1L on LPL, we determinedwhether Sel1L interactswith LPL. In
HEK293T cells, exogenous and endogenous Sel1L protein inter-
acted strongly with transfected LPL (Figures 7A and S7A). N-ter-
minal domain (1–339 aa) of LPL that contains the lipolytic active(I) Immunoblots of LPL in primary adipocytes either mock-treated (-) or treated w
(BFA) in the presence of 1 mg/ml insulin for 4 hr. Arrowhead points to the deglyc
(J and K) Immunoblots of UPR genes (J) and LPL (K) in WAT of WT, HET, and AK
shown below.
(L) Immunoblots of Sel1L and LPL in the culture medium and cells of primary adip
10 U/ml heparin. Protein levels relative to WT shown below the blot.
(M) Plasma TG levels of WT, HET, and AKO mice refed HFD for 4 hr after an ove
Data are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. HSP
S4–S6.
Cell Mesite was sufficient to interact with Sel1L (Figure S7B). Sel1L
also interacted with LMF1 in transfected HEK293T cells (Fig-
ure 7B). Interestingly, the interaction between LPL and LMF1
was dramatically augmented with the addition of Sel1L (Fig-
ure 7Cc, lane 2 versus lane 4). On the other hand, LMF1 had no
effect on the Sel1L-LPL interaction (Figure 7Ce, lane 1 versus
lane 4). Thus, these data suggest that Sel1L, LPL, and LMF1
form a complex where Sel1L may help stabilize the complex.
We next asked whether Hrd1 is present in the Sel1L-LPL com-
plex. Hrd1 interacted strongly with Sel1L (Figure 7De), but not
LPL (Figure 7Dd). Strikingly, addition of Hrd1 dramatically atten-
uated the Sel1L-LPL interaction (Figure 7Df, lane 3 versus lane
4), suggesting that Hrd1 competes with LPL for Sel1L. Similarly,
addition of Hrd1 also greatly reduced the interaction between
Sel1L and LMF1 (Figure 7Ed, lane 3 versus lane 4), suggesting
that Hrd1 competes with LMF1 for Sel1L.
DISCUSSION
Mammalian Sel1L is an essential component of the Hrd1 ERAD
complex in vivo (Sun et al., 2014). Here our data demonstrate
that Sel1L forms a functional complex with LPL-LMF1 on theith 5 mg/ml tunicamycin (Tm), 300 nM thapsigargin (Tg), or 1 mg/ml brefeldin A
osylated LPL in Tm-treated samples.
O mice refed LFD for 4 hr after an overnight fast. In (K), endoH analysis of LPL
ocytes fromWT, HET, and AKOmice incubated for 4 hr with 2 mg/ml insulin and
rnight fast (n = 6 each).
90, a loading control. l.e., long exposure; a.u., arbitrary unit. See also Figures
tabolism 20, 458–470, September 2, 2014 ª2014 Elsevier Inc. 465
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Figure 6. Sel1L Regulates the ER Exit of LPL Dimers and Prevents LPL Aggregation
(A) Sucrose gradient analysis of LPL in WAT lysates from WT and AKO mice refed HFD for 3 hr following an overnight fast. Quantitation of LPL mass in each
fraction shown above. Fractions with LPL dimers and high-molecular-weight (HMW) complex are indicated. Relative amount and percent of LPL in each
configuration are shown below the blot.
(B) Immunoblots of LPL in the NP40-soluble (NP40S) and -insoluble (NP40P) fractions of primary adipocytes cultured at 4C or 37C for 3 hr. Bag6 and H2Amark
the NP40S and NP40P fractions, respectively. Quantitation of LPL shown below the blots. A line graph is shown below to illustrate the dynamic movement of LPL
from NP40S to NP40P at 37C.
(C) Quantitation and immunoblots (lower) of LC3 in WAT of WT and AKO mice refed HFD for 3 hr following an overnight fast (n = 6 each).
(D) EndoH analysis of LPL in the fractions and WAT lysates collected from (A). Quantitation of the percent of each LPL form shown below the blots.
(E) LPL activity and immunoblots of LPL, Sel1L, and LMF1 (below) in WAT of Lmf1+/+ and inducible Lmf1/mice (left, n = 3 each) and WAT of WT and AKOmice
refed HFD for 3 hr following an overnight fast (right, n = 6 each). Quantitation of LPL mass shown below the blot.
Data are mean ± SEM. *p < 0.05, ***p < 0.001 by Student’s t test. HSP90, a loading control.
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trols ERAD of misfolded proteins in the ER and thereby ER ho-
meostasis, the Sel1L-LPL-LMF1 complex controls the ER exit
and secretion of LPL dimers, thereby regulating systemic lipid
partitioning (Figure 7F). Our data show that deficiency of Sel1L
in adipocytes leads not only to ERAD deficiency and activation
of UPR, but also to intracellular retention of LPL and postprandial
hypertriglyceridemia. The Sel1L-LPL-LMF1 complex helps sta-
bilize nascent LPL dimers and prevent aggregation, allowing
the ER exit of LPL dimers. In the absence of Sel1L, LPL is trap-
ped in the ER in the form of ERAD-resistant aggregates, which
are degraded by autophagy.
Although LPL has been extensively studied in the last half-cen-
tury, the mechanism by which active LPL dimers are secreted
from the ER remains a mystery. Investigation into hypertriglycer-
idemia of AKOmice has led us to the discovery of an unexpected466 Cell Metabolism 20, 458–470, September 2, 2014 ª2014 Elseviefunction of Sel1L in LPL biology. Based on our data, we propose
that Sel1L interacts with both LMF1 and LPL; upon the formation
of active LPL dimers catalyzed by LMF1, Sel1L stabilizes LPL,
prevents its aggregation, and ensures the exit of transport-
competent LPL from the ER (Figure 7F). In the absence of
Sel1L, active LPL dimers are trapped and may dissociate into
monomers, leading to aggregation (Figure 7F). Thus, Sel1L
may act as a substrate-specific chaperone to stabilize LPL,
similar to the situation for the E3 ligase Hrd1 (Gardner et al.,
2000; Sun et al., 2014). In the future, more studies are required
to further identify other Sel1L targets as well as protein compo-
nents in the Sel1L-LPL complex.
Here we focused our attention on the role of Sel1L in LPL
because of the novelty of this finding and because of its rele-
vance to the hyperlipoproteinemia syndrome in humans. How-
ever, this is unlikely to be the sole role of Sel1L in adipose tissue,r Inc.
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Figure 7. Sel1L Forms a Complex with LPL and LMF1, Independent of Hrd1
(A) Sel1L interacts with LPL. Coimmunoprecipitation (coIP) analysis in LPL and Sel1L-GFP-transfected HEK293T cells.
(B) Sel1L interacts with LMF1. CoIP analysis in Sel1L-GFP and LMF1-Myc-transfected HEK293T cells.
(C) Sel1L enhances the interaction between LPL and LMF1. CoIP analysis in LPL, Sel1L-GFP, and LMF1-Myc-transfected HEK293T cells.
(D) Hrd1 competes with LPL for Sel1L. CoIP analysis in Hrd1-Myc, Sel1L-GFP, and LPL-V5-transfected HEK293T cells.
(E) Hrd1 competes with LMF1 for Sel1L. CoIP analysis in Hrd1-Myc, Sel1L-HA, and LMF1-Myc-transfected HEK293T cells.
(F) A model for Sel1L-regulated LPL secretion. LMF1 is responsible for the maturation of LPL monomers into functional dimers. Sel1L may stabilize LPL dimers
through the Sel1L-LPL-LMF1 complex, allowing the ER exit of LPL dimers. In Sel1L-deficient cells (lower), LPL dimers become unstable, are trapped in the ER,
dissociate into monomers, and form aggregates. LPL aggregates are degraded primarily by autophagy.
See also Figure S7.
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Role of Sel1L and Sel1L-Hrd1 ERAD in Adipocytesas adipocyte-specific LPL knockout mice on HFD exhibit a mild
metabolic phenotype without changes in either body or fat
weights (Garcia-Arcos et al., 2013). Therefore, the lean pheno-
type of the AKO mice on HFD is likely due to other functions of
Sel1L, such as UPR. Given that Grp78+/ mice exhibit a similar
lean phenotype on HFD (Ye et al., 2010), we speculate that
chronic UPR may lead to the resistance to diet-induced obesity
in AKO mice. How alterations in ER homeostasis affect meta-
bolic phenotype remains an interesting question. Our data
showed that UPR in AKO mice is uncoupled from inflammationCell Meand cell death, thus excluding the possible involvement of the
latter two in the resistance to diet-induced obesity. Future
studies are required to elucidate the physiological role of Sel1L
and the Sel1L-Hrd1 ERAD complex in WAT as well as in other
tissues.
To date, little is known about the impact of the accumulation of
misfolded proteins in vivo at the tissue and organismal levels.
In vitro, when challenged with insurmountable ER stress induced
by pharmacological drugs that cause the accumulation of mis-
folded proteins, cells undergo apoptosis through the activationtabolism 20, 458–470, September 2, 2014 ª2014 Elsevier Inc. 467
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Role of Sel1L and Sel1L-Hrd1 ERAD in Adipocytesof three branches of the UPR (Rutkowski and Kaufman, 2007).
However, UPR associated with physiological conditions is likely
to be mild. Our data show that the UPR induced by Sel1L and
Hrd1 deficiency in adipocytes is well tolerated by the cell as
mice appear largely normal at the first several months of life on
LFD as well as at the beginning several weeks of HFD feeding.
Providing further support, inflammation and apoptosis are un-
coupled from the UPR in WAT of AKO mice. The moderate
UPR in AKO WAT may occur through three adaptive mecha-
nisms. First, other ERAD complexes (Smith et al., 2011) may
compensate the Sel1L-Hrd1 defects. Indeed, a recent study
showed the compensatory functions between the Hrd1 and
Gp78 E3 ligases (Bernasconi et al., 2010). Second, elevated
expression of ER chaperones and foldases in WAT of AKO
mice is likely to increase folding capacity and reset homeostasis
in the ER. Lastly, activation of PERK pathway in WAT and AKO
mice may reduce the protein load into the ER. Thus, cellular
adaption to the Sel1L-Hrd1 ERAD deficiency in adipocytes
may lead to a low-grade chronic UPR, uncoupled from apoptosis
and inflammation. This conclusion may provide important in-
sights into (patho)-physiological UPR.
Cell-type-specific ERAD function remains largely unknown.
Our data showed that AKO mice are resistant to diet-induced
obesity and exhibit postprandial hypertriglyceridemia. As Sel1L
deficiency also causes downregulation of Hrd1, our AKO mice
indeed represent a Sel1L-Hrd1 double-null mouse model. A
recent study using liver-specific Hrd1-null mice showed that
Hrd1 interacts and degrades Nrf2 to compromise antioxidant
response in liver cirrhosis (Wu et al., 2014). Moreover, liver-
specific Gp78-null mice result in Insig-1/2 accumulation, thereby
downregulating SREBP-mediated lipogenesis (Liu et al., 2012).
The nature of the Sel1L-Hrd1 ERAD substrates requires further
investigation.
Proteasome-mediated ERAD is the best-characterized protein
degradation pathway for misfolded proteins in the ER. One of the
outstanding questions in the ERAD field is the substrate recogni-
tion by various ERAD complexes. In a recent study, we showed
that OS9 and EDEM1, two chaperone proteins in the ER, accu-
mulate in Sel1L-deficient pancreas (Sun et al., 2014). Similarly,
OS9 and EDEM1 are highly upregulated in AKO WAT without
transcriptional upregulation, indicative of an ERAD deficiency
in AKO cells and pointing to OS9 and EDEM1 as Hrd1 sub-
strates. By contrast, while LPL accumulates in the ER of
Sel1L-deficient cells, it is not a result of ERAD deficiency, and
LPL is not a Sel1L-Hrd1 ERAD substrate. Rather, LPL is consti-
tutively degraded by autophagy regardless of Sel1L status. LPL
aggregation in Sel1L-deficient cells is due to the blockade of
LPL secretion, rather than ERAD deficiency. This conclusion
was further supported by our observation pointing to Sel1L hap-
loinsufficiency on LPL secretion, but not on UPR. Finally, using
an overexpression system in HEK293T cells, our data show
that Sel1L physically interacts with LPL and LMF1 as well as pro-
motes the interaction between LPL and LMF1. While more
studies are required to examine the formation of endogenous
protein complex, these data provide strong evidence that
Sel1L directly affects LPL secretion in the ER in an Hrd1/
ERAD-independent manner.
Our data show that degradation of ER-retained LPL aggre-
gates requires autophagy, in line with an earlier study (Ben-468 Cell Metabolism 20, 458–470, September 2, 2014 ª2014 ElsevieZeev et al., 2002). This situation resembles what has been
reported for the degradation of other ER-resident proteins
such as apolipoprotein B100 and B48 (Ohsaki et al., 2006; Qiu
et al., 2011), and abnormal ER proteins such as the a1 antitrypsin
Z mutant (Hidvegi et al., 2010; Teckman and Perlmutter, 2000),
gonadotropin-releasing hormone receptor mutants (Houck
et al., 2014), and dysferlin (Fujita et al., 2007). A recent study sug-
gested that downregulation of ERAD activity may promote the
clearance of misfolded proteins in the ER via autophagy (Houck
et al., 2014). Thus, autophagy may act to complement the
function of the ERAD pathways to clear misfolded proteins or
aggregates from the ER. However, how autophagy mediates
the degradation of LPL aggregates remains unclear.
Increasing evidence suggests that persistent postprandial hy-
pertriglyceridemia contributes to the development of atheroscle-
rosis and coronary artery disease (Chan et al., 2013). Thus, our
findings may have therapeutic implications. Recent discovery
of LMF1, GPIHBP1, and ANGPTL4 has provided key insights
into LPL biology, where they play key roles at different stages
of LPL maturation and function (Dijk and Kersten, 2014; Doolittle
and Peterfy, 2010; Wang and Eckel, 2009). In this study, we have
identified Sel1L as amodulator of LPL secretion from the ER. The
LMF1-LPL-Sel1L interaction or Sel1L stability may be targeted
therapeutically by small molecules to enhance the folding and
secretion efficacy of LPL, hence reducing hyperlipidemia associ-
ated with metabolic syndrome.EXPERIMENTAL PROCEDURES
Mice
Sel1Lflox/flox mice have been recently described (Sun et al., 2014) and crossed
with adiponectin promoter-driven Cre mice (Eguchi et al., 2011) (gift from
Dr. Evan Rosen), which have been backcrossed to the C57BL/6J background
for more than five generations. Figures S1J and S1K show different breeding
schemes to generate adipocyte-specific Sel1L/ (AKO) and Sel1L+/ (HET)
mice. Additionally, the Sel1Lflox/flox animals were crossed with lysozyme 2 pro-
moter-driven Cre mice on the B6 background (JAX 004781) to generate MKO
mice. Inducible Sel1L-deficient mice (IKO) were generated and injected with
tamoxifen as we recently described (Sun et al., 2014). All animal procedures
associated with Sel1L-null mice have been approved by the Institutional
Animal Care and Use Committee (IACUC) at Cornell University (#2007-0051).
To generate mice with LMF1-deficient adipose tissue, mice carrying a floxed
allele of Lmf1 were crossed with tamoxifen-inducible Cre-transgenic mice
(UBC-CreER, JAX #7001). LMF1 deficiency was induced by tamoxifen injec-
tions at 6 weeks of age. Studies with Lmf1-null mice were approved by the
IACUC at the Cedars-Sinai Medical Center. Cohoused age- and gender-
matched littermates were used in all in vivo experiments.Metabolic Phenotyping
Blood glucose levels, glucose tolerance test (GTT, 1 g glucose/kg body
weight), and insulin tolerance test (ITT, 2 U insulin/kg body weight) were per-
formed as previously described (Sha et al., 2014). EF and livers were har-
vested, weighed, and fixed for histology or snap-frozen for western blot and
qPCR. Fat and leanmasses were measured using DEXA (PIXImus, GEMedical
Systems Lunar) per manufacturer’s instruction. Blood was collected from ju-
gular vein. Serum insulin levels were measured using the ELISA kit (Millipore)
per supplier’s protocol. TG levels in the plasma or serumwere measured using
Sigma GPO-Trinder kit (#TR0100, Sigma-Aldrich) per manufacturer’s instruc-
tion. Tomeasure hepatic TG content, the liver was homogenized in 10 ml buffer
(10 mM Tris-Cl, 2 mM EDTA, 0.25 M sucrose [pH 7.5]) per mg of liver using
Polytron (PRO Scientific). In a 96-well plate, 3 ml of homogenate was used
for TG measurement. Lipoprotein profiling using FPLC was performed as pre-
viously described (Lichtenstein et al., 2007).r Inc.
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Female mice 19 weeks old on LFD were fasted for 18 hr followed by refeeding
with HFD for 2 hr. Mice were injected i.v. with 60 U (per mouse) of heparin
sodium (VWR) in 0.9% NaCl solution, and blood was obtained from the
retro-orbital plexus 10 min later. LPL levels in the postheparin plasma were
determined using ELISA as previously described (Weinstein et al., 2008).
LPL activity was determined using a lecithin-stabilized radiolabeled triolein
(glycerol tri[9,10(n)-3H]oleate) substrate and normalized by total protein as
described (Briquet-Laugier et al., 1999). WAT was collected from 16-week-
old WT and AKO female mice refed HFD for 3.5 hr following an 18 hr fast, as
well as Lmf1/ and their WT littermates fasted for 4 hr. WAT was homoge-
nized at 100 mg/ml in a buffer containing 10 mM Tris-HCl (pH 7.5), 0.2% Na-
deoxycholate, and 10 U/ml heparin, and protein concentration was assayed
using the bicinchoninic acid (BCA) assay (Pierce).
LPL Secretion
Isolated primary adipocytes from WAT were plated at 30% (v/v) confluency in
six-well plates in KRBH buffer containing 1–2 mg/ml insulin (Sigma) and with or
without 10 U/ml heparin. After culture for 4–6 hr, medium was harvested and
concentrated using Microsep 10K (Pall), and primary adipocytes were
collected for cell lysates. Medium and cell lysates were subjected to western
blot analysis. Freshly differentiated BMDMs fromWT andMKOmice were pre-
pared as previously described (Sun et al., 2012) and at day 6 were washed by
PBS and incubated in DMEM medium supplemented with 2 mM intralipid and
10 U/ml heparin in the absence of serum for 3 hr. LPL levels in the cells and
medium were determined as above.
Drug Treatment in Primary Adipocytes
Isolated primary adipocytes from WAT were plated at 30% (v/v) confluency in
six-well plates in KRBH buffer containing 1 mg/ml insulin and treated with
various drugs including 5 mg/ml Tm or 300 nM Tg to induce ER stress,
1 mg/ml BFA to block protein secretion, 50 mg/ml CHX to block protein trans-
lation, 5 mM 3-MA or 200 mM chloroquine to inhibit autophagy, and 25 mM
MG132 to inhibit proteasomal degradation. At the end of treatment, adipo-
cytes and/or culture medium were collected for western blots. For the transla-
tional shut-off assay (Figure 5B), primary adipocytes were maintained in KRBH
buffer containing 1 mg/ml insulin and 1 mg/ml BFA for a total of 6 hr, during which
various combinations of drugs were added at 0, 2, and 4 hr. Cells were
collected at the same time at the 6 hr time point.
Statistical Analysis
Band density was quantitated using the Image Lab software on the ChemiDOC
XRS+ system (Bio-Rad) or ImageJ (NIH). Experimental results are expressed
as mean ± SEM. Comparisons between groups were made by unpaired
two-tailed Student’s t test, where p < 0.05 was considered statistically signif-
icant. Gene Expression Omnibus (GEO) accession number for the microarray
is GSE56918.
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